 reversal left ventricular hypertrophy hypertension beneficial left ventricle mass wall thickness hypertension result progressive increase hemodynamic overload arterial blood pressure total peripheral resistance evidence nonhemodynamic factors important development left ventricular hypertrophy LVH LVH hypertensive disease conveys independent risk premature cardiovascular morbidity mortality specific mechanisms risk assurance several mechanisms active study ventricular dysrhythmias myocardial ischemia possible ventricular mass pharmacological agents reversal risk LVH present time means risk LVH development first place preventable control arterial blood pressure stages hypertension Risk patients LVH digitalis diuretics fluid- electrolyte-disturbing diseases circumstances careful use selection antihypertensive therapy control electrolyte balance doubt unnecessary morbidity mortality